Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-01-05 @ 6:18 PM
Study NCT ID:
NCT03886493
Status:
TERMINATED
Last Update Posted:
2021-10-15
First Post:
2019-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-20
First Submit QC Date:
None
Study First Post Date:
2019-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-17
Results First Submit QC Date:
None
Results First Post Date:
2021-10-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-17
Last Update Post Date:
2021-10-15
Last Update Post Date Type:
ACTUAL